{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:37:52Z","timestamp":1768585072388,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.jjcc.2016.03.014","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T22:32:29Z","timestamp":1461969149000},"page":"228-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Evaluation of safety and efficacy of periprocedural use of rivaroxaban and apixaban in catheter ablation for atrial fibrillation"],"prefix":"10.1016","volume":"69","author":[{"given":"Akino","family":"Yoshimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhisa","family":"Iriki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ichiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Oketani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Okui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Maenosono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuminori","family":"Namino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Ohishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2016.03.014_bib0255","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: The Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0260","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.28.10.973","article-title":"Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study","volume":"28","author":"Wolf","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0265","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(09)60443-8","article-title":"Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study","volume":"373","author":"Schnabel","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0270","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9343(99)80348-9","article-title":"The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba Follow-Up Study","volume":"98","author":"Krahn","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0275","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/01.CIR.99.23.3028","article-title":"Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists","volume":"15","author":"Levy","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0280","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0285","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1161\/STROKEAHA.110.590257","article-title":"Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort","volume":"41","author":"Lip","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0290","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/eurheartj\/ehs031","article-title":"Putting risk prediction in atrial fibrillation into perspective","volume":"33","author":"Piccini","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0295","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-151-5-200909010-00003","article-title":"The net clinical benefit of warfarin anticoagulation in atrial fibrillation","volume":"151","author":"Singer","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0300","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0305","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1161\/CIRCULATIONAHA.113.006426","volume":"129","author":"Di Biase","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0310","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0315","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0320","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0325","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199809033391003","article-title":"Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins","volume":"339","author":"Haissaguerre","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0330","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1001\/jama.293.21.2634","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial","volume":"293","author":"Wazni","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0335","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0735-1097(03)00577-1","article-title":"Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study","volume":"42","author":"Pappone","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0340","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/01.CIR.0000157153.30978.67","article-title":"Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation","volume":"111","author":"Cappato","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0345","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/eurheartj\/ehi583","article-title":"Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study)","volume":"27","author":"Stabile","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0350","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.107.691386","article-title":"Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms","volume":"115","author":"Oral","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0355","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.jacc.2003.12.054","article-title":"A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate","volume":"43","author":"Nademanee","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0360","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/eurheartj\/ehq079","article-title":"Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation","volume":"31","author":"Nault","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0365","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/CIRCEP.109.859116","article-title":"Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation","volume":"3","author":"Cappato","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0370","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1046\/j.1460-9592.2001.01774.x","article-title":"Empirical pulmonary vein isolation in patients with chronic atrial fibrillation using a three-dimensional nonfluoroscopic mapping system: long-term follow-up","volume":"24","author":"Kanagaratnam","year":"2001","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0375","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/hc0902.104712","article-title":"Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation","volume":"105","author":"Oral","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0380","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1093\/eurheartj\/ehl093","article-title":"Substrate modification combined with pulmonary vein isolation improves outcome of catheter ablation in patients with persistent atrial fibrillation: a prospective randomized comparison","volume":"27","author":"Willems","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0385","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jacc.2007.10.044","article-title":"Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation","volume":"51","author":"Nademanee","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jjcc.2009.11.002","article-title":"Catheter ablation of atrial fibrillation guided by complex fractionated atrial electrogram mapping of atrial fibrillation substrate","volume":"55","author":"Nademanee","year":"2010","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0395","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jjcc.2011.07.006","article-title":"Relationship between clinical outcomes and unintentional pulmonary vein isolation during substrate ablation of atrial fibrillation guided solely by complex fractionated atrial electrogram mapping","volume":"58","author":"Iriki","year":"2011","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0400","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.ijcard.2012.12.006","article-title":"Atrial fibrillation-induced endothelial dysfunction improves after restoration of sinus rhythm","volume":"168","author":"Yoshino","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0405","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/europace\/eun244","article-title":"Electrogram-guided substrate ablation with or without pulmonary vein isolation in patients with persistent atrial fibrillation","volume":"10","author":"Estner","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0410","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/CIRCULATIONAHA.110.937953","article-title":"Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation","volume":"122","author":"Gaita","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0415","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1540-8167.2009.01540.x","article-title":"Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation","volume":"20","author":"Scherr","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0420","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/europace\/eup350","article-title":"Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation","volume":"12","author":"Schrickel","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0425","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1540-8167.2005.00337.x","article-title":"Silent cerebral thromboembolism with left atrial ablation: a lurking danger","volume":"17","author":"Asirvatham","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0430","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1046\/j.1540-8167.2002.00764.x","article-title":"Cerebrovascular complication associated with pulmonary vein ablation","volume":"13","author":"Kok","year":"2002","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0435","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1540-8167.2011.02259.x","article-title":"Incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation guided by complex fractionated atrial electrogram","volume":"23","author":"Ichiki","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0440","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1161\/CIRCULATIONAHA.109.921320","article-title":"Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio","volume":"121","author":"Di Biase","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0445","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.thromres.2009.11.031","article-title":"Peri-procedural anticoagulation in patients undergoing ablation for atrial fibrillation","volume":"126","author":"Vazquez","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0450","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.hrthm.2009.07.007","article-title":"Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy","volume":"6","author":"Hussein","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0455","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/CIRCULATIONAHA.107.727784","article-title":"Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period","volume":"116","author":"Wazni","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0460","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/pace.12195","article-title":"The incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation: comparison of warfarin and dabigatran","volume":"36","author":"Ichiki","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0465","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/CIRCEP.113.000320","article-title":"Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation","volume":"6","author":"Bassiouny","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0470","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10840-012-9708-z","article-title":"A comparison of bleeding complications post-ablation between warfarin and dabigatran","volume":"35","author":"Snipelisky","year":"2012","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0475","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/heartjnl-2013-304386","article-title":"Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis","volume":"100","author":"Providencia","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0480","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.joa.2014.04.006","article-title":"The optimal setting of complex fractionated atrial electrogram software in substrate ablation for atrial fibrillation","volume":"31","author":"Namino","year":"2015","journal-title":"J Arrhythmia"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0485","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jjcc.2012.02.009","article-title":"Effectiveness of esophagus detection by three-dimensional electroanatomical mapping to avoid esophageal injury during ablation of atrial fibrillation","volume":"60","author":"Maenosono","year":"2012","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0490","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.joa.2012.05.011","article-title":"Catheter ablation of atrial fibrillation guided by complex fractionated atrial electrogram mapping with or without pulmonary vein isolation","volume":"28","author":"Oketani","year":"2012","journal-title":"J Arrhythmia"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0495","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0b013e3181e7c9dd","volume":"75","author":"Schellinger","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jjcc.2016.03.014_bib0500","article-title":"Ablation perioperative dabigatran in use envisioning in Japan: The ABRIDGE-J Study Design","author":"Goya","year":"2015","journal-title":"J Cardiol"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508716300417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508716300417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:57:20Z","timestamp":1760273840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508716300417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0914508716300417"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2016.03.014","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of safety and efficacy of periprocedural use of rivaroxaban and apixaban in catheter ablation for atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2016.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}